Latest News about Eli Lilly And Co
Recent news which mentions Eli Lilly And Co
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
From CNBC.com News
Treasury yields dip slightly as Fed trajectory remains in focus
December 20, 2023
From CNBC.com News
Treasury yields down slightly as recent trend continues
December 19, 2023
From CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
From CNBC.com News
Treasury yields inch higher ahead of Fed meeting
December 11, 2023
From CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
December 07, 2023
From CNBC.com News
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
From CNBC.com News
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
From CNBC.com News
This key element of ESG investing could drive real change at companies and boost returns
November 18, 2023
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
From CNBC.com News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
October 30, 2023
From CNBC.com News
From CNBC.com News
Treasury yields continue retreat after 10-year slips back below 5%
October 24, 2023
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
From CNBC.com News
Treasury yields rise again as 10-year hovers near 5%
October 23, 2023
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
